# Efficacy, Safety and Tolerability of Eziclen®/Izinova® Versus Klean-prep® on Bowel Cleansing in Adolescents Undergoing Colonoscopy

> **NCT03008460** · PHASE3 · COMPLETED · sponsor: **Ipsen** · enrollment: 250 (actual)

## Conditions studied

- Digestive System Disease

## Interventions

- **DRUG:** Eziclen®/Izinova®
- **DRUG:** Klean-Prep®

## Key facts

- **NCT ID:** NCT03008460
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-15
- **Primary completion:** 2020-02-24
- **Final completion:** 2020-06-29
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2021-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03008460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03008460, "Efficacy, Safety and Tolerability of Eziclen®/Izinova® Versus Klean-prep® on Bowel Cleansing in Adolescents Undergoing Colonoscopy". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03008460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*